Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fragment-to-Lead Medicinal Chemistry Publications in 2021
Louise Walsh, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1137-1156
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
A. Douangamath, A.J. Powell, D. Fearon, et al.
Journal of Visualized Experiments (2021), Iss. 171
Open Access | Times Cited: 58
Fragment-to-Lead Medicinal Chemistry Publications in 2022
Andrew J. Woodhead, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2287-2304
Closed Access | Times Cited: 11
Fragment-to-Lead Medicinal Chemistry Publications in 2023
Rhian S. Holvey, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2025) Vol. 68, Iss. 2, pp. 986-1001
Closed Access
Different applications and differentiated libraries for crystallographic fragment screening
Jessica E. Watt, Mathew P. Martin, Jane Endicott, et al.
Current Opinion in Structural Biology (2025) Vol. 90, pp. 102982-102982
Open Access
The rise of NMR-integrated fragment-based drug discovery in China
Zihuan Li, Lei Wang, Jia Gao, et al.
Magnetic Resonance Letters (2025), pp. 200179-200179
Open Access
Fragment Screening Identifies Novel Allosteric Binders and Binding Sites in the VHR (DUSP3) Phosphatase
Jiaqian Wu, Marek R. Baranowski, Alexander E. Aleshin, et al.
ACS Omega (2025)
Open Access
ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy
Xing-Xing Shi, Zhi-Zheng Wang, Fan Wang, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. W1, pp. W25-W32
Open Access | Times Cited: 13
Harvesting phosphorus-containing moieties for their antibacterial effects
Manuela Voráčová, Matej Zore, Jari Yli‐Kauhaluoma, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117512-117512
Open Access | Times Cited: 13
Linkers in fragment-based drug design: an overview of the literature
D. Grenier, Solène Audebert, Jordane Preto, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 987-1009
Closed Access | Times Cited: 10
Fragment-based drug discovery campaigns guided by native mass spectrometry
Louise M. Sternicki, Sally‐Ann Poulsen
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2270-2285
Closed Access | Times Cited: 3
Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells
Jordan M. Mattheisen, Chris Limberakis, Roger B. Ruggeri, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 20, pp. 11173-11184
Open Access | Times Cited: 9
Design and Evaluation of a Low Hydrogen Bond Donor Count Fragment Screening Set to Aid Hit Generation of PROTACs Intended for Oral Delivery
Benjamin C. Whitehurst, Matthias R. Bauer, Fredrik Edfeldt, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7594-7604
Closed Access | Times Cited: 9
Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors
Edward A. Fitzgerald, Darius Vagrys, Giulia Opassi, et al.
SLAS DISCOVERY (2023) Vol. 29, Iss. 1, pp. 40-51
Open Access | Times Cited: 9
FragGrow: A Web Server for Structure-Based Drug Design by Fragment Growing within Constraints
Yueqing Zhang, Zhihan Zhang, Dongliang Ke, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 3970-3976
Closed Access | Times Cited: 2
Coumarins as factor XIIa inhibitors: Potency and selectivity improvements using a fragment-based strategy
Clara Davoine, Amandine Traina, Jonathan Evrard, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115636-115636
Closed Access | Times Cited: 5
Examining molecular factors of inactive versus active bivalent EGFR inhibitors: A missing link in fragment-based drug design.
Florian Wittlinger, Blessing C. Ogboo, Calvin D. Pham, et al.
(2023)
Open Access | Times Cited: 3
Advances in analytical technologies detecting and characterizing noncovalent interactions for fragment-based drug discovery
Clara Davoine, Lionel Pochet, Marianne Fillet
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117161-117161
Closed Access | Times Cited: 3
Fragment-Based Discovery of Novel VE-PTP Inhibitors Using Orthogonal Biophysical Techniques
Wataru Asano, Kenji Yamanaka, Yasunori Ohara, et al.
Biochemistry (2023) Vol. 62, Iss. 14, pp. 2161-2169
Closed Access | Times Cited: 3
QM assisted ML for 19F NMR chemical shift prediction
Patrick Penner, Anna Vulpetti
Journal of Computer-Aided Molecular Design (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
Fragment-based and structure-guided discovery of perforin inhibitors
Jiney Jose, Ruby H. P. Law, Eleanor W. W. Leung, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115786-115786
Open Access | Times Cited: 2
QM Assisted ML for 19F NMR Chemical Shift Prediction
Patrick Penner, Anna Vulpetti
(2023)
Open Access | Times Cited: 2
Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines
Elizabeth V. Bedwell, Flávio da Silva Emery, Giuliano C. Clososki, et al.
RSC Advances (2023) Vol. 13, Iss. 49, pp. 34391-34399
Open Access | Times Cited: 2
Evaluating the use of absolute binding free energy in the fragment optimization process.
Irfan Alibay, Aniket Magarkar, Daniel Seeliger, et al.
(2022)
Open Access | Times Cited: 4
Synthesis and Chemoinformatic Analysis of Fluorinated Piperidines as 3D Fragments for Fragment-Based Drug Discovery
Myriam Le Roch, Jacques Renault, Gilles Argouarch, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 7, pp. 4932-4946
Open Access
ChemoDOTS: a web server to design chemistry-driven focused libraries
Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. W1, pp. W461-W468
Open Access
Page 1 - Next Page

Scroll to top